Opportunities in Immuno-Oncology Drug Discovery in Redwood City, CA
Collaborate with forward-thinking scientists in our fully integrated, state-of-the-art research facility in the San Francisco Bay Area.
Our Bay Area research facility is located in the midst of San Francisco’s life sciences and high-tech communities. Our location in Redwood City offers an ideal environment that fosters external collaboration with others in the biopharma and academic communities.
Explore our current job openings in Redwood City, California
Transformative science delivered in an exceptional setting.
Join our science-driven and passionate Research and Development (R&D) organization in Redwood City and help discover, develop and deliver medicines that have the potential to transform the lives of patients and establish new standards of care in areas of high unmet need.
Bristol-Myers Squibb is transforming the way certain cancers are treated with the goal of changing the expectations and outcomes of cancer therapy. Our researchers in Redwood City pioneered targeting the immune system in cancer research and we continue to break new ground in the science of Immuno-Oncology. Our oncology pipeline is robust, with several experimental compounds in development.
Make a difference today in our Bay Area Research & Development facility in open positions in:
- Immuno-Oncology Resistance Biology
- Early Discovery Immuno-Oncology Biology
- Protein Therapeutics and Automation
The importance of our work in Redwood City.
Our recently expanded research center in the Bay Area will continue to serve as a hub for discovering novel biologics therapeutics. Our deep understanding of both tumor and immune biology reveals multiple opportunities for therapeutic intervention, including precision-based medicine. At Redwood City, our team is focused on understanding the mechanisms of Immuno-Oncology resistance with the goal to facilitate fast, real-time decisions that can inform the science in earlier stages.
As a member of our team, you will help us anticipate what’s coming next, navigate and discover new technologies, and apply them to advance drug discovery, development and delivery to patients as quickly as possible.
Our Bay Area research facility houses biologics drug discovery activities focused on antibody therapeutics and positions our scientists in proximity to biomedical research centers.
Bryan C. Barnhart, senior director of Immuno-Oncology at Bristol-Myers Squibb Redwood City, explains why scientists are targeting immune system pathways to treat cancer, how antibodies can be engineered to act most effectively and where immunotherapy may be headed in the future as more treatment targets emerge.
